1. Matito A, Morgado JM, Sánchez-López P, Álvarez-Twose I, SánchezMuñoz L, Orfao A. Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish network on Mastocytosis (REMA) based on 726 anesthetic procedures. Int Arch Allergy Immunol. 2015;167:47-56.

2. Chaar CI, Bell RL, Duffy TP, Duffy AJ. Guidelines for safe surgery in patients with systemic mastocytosis. Am Surg. 2009;75(1):74-80.

3. Scott HW Jr, Parris WC, Sandidge PC, Oates JA, Roberts LJ. Hazards in operative management of patients with systemic mastocytosis. Ann Surg. 1983;197(5):507-14.

4. Hagen A, Doldersum P, Raaij T. Anaphylactic shock during cement implantation of a total hip arthroplasty in a patient with underlying mastocytosis: case report of a rare intraoperative complication. Patient Saf Surg. 2016;10:25.

5. Carter MC, Metcalfe DD, Matito A, Escribano L, Butterfield JH, Schwartz LB, et al. Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: a work group report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2019;143:880-93.

6. Lepelley M, Khouri C, Pralong P, Rossignol J, Greco C, Bouillet L, et al. Which opioids in case of mast cell activation disorders? J Allergy Clin Immunol Pract. 2019;7(4):1317-8.

7. McNeil BD, Pundir P, Meeker S, Han L, Undem BJ, Kulka M, Dong X. Identification of a mast-cell-specific receptor crucial for pseudoallergic drug reactions. Nature. 2015;519:237-41.